Table 2.
Demographic and Clinical Characteristics by HIV Disclosure Status
| Characteristic, n (%) | No disclosure (n = 205) | Any disclosurea(n = 1724) | Total (N = 1929) | pb |
|---|---|---|---|---|
| Age,c years | 41 (15) | 39 (17) | 39 (16) | 0.0080 |
| Residence | 0.7050 | |||
| Rural | 37 (18) | 293 (17) | 330 (17) | |
| Urban | 168 (82) | 1431 (83) | 1599 (83) | |
| Living status | <0.0001 | |||
| Alone | 86 (42) | 328 (19) | 414 (22) | |
| With others | 52 (25) | 397 (23) | 449 (23) | |
| With partner/husband | 67 (33) | 999 (58) | 1066 (55) | |
| Serodiscordant with partnerd | 27 (40) | 486 (49) | 513 (48) | 0.0003 |
| Employed | 119 (58) | 894 (52) | 1013 (53) | 0.2164 |
| Born in country of residence | 139 (68) | 1382 (80) | 1521 (79) | 0.0008 |
| Family/friend support | 48 (23) | 1111 (64) | 1159 (60) | <0.0001 |
| Time from diagnosis to enrollment, years | 6.3 (7.9)c | 8.0 (9.6)c | 7.8 (9.4)c | 0.0215 |
| <1 | 15 (7) | 103 (6) | 118 (6) | |
| 1–5 | 78 (38) | 538 (31) | 616 (32) | |
| >5–10 | 57 (28) | 427 (25) | 484 (25) | |
| >10 | 46 (22) | 587 (34) | 633 (33) | |
| Unknown | 9 (4) | 69 (4) | 78 (4) | |
| Latest viral load <50 copies/mL | 126 (62) | 985 (57) | 1111 (58) | 0.4036 |
| Last recorded CD4+ count,c cells/mL | 482 (331) | 517 (395) | 513 (386) | 0.9406 |
| Use of antiretroviral therapy | 0.1526 | |||
| Never | 20 (10) | 136 (8) | 156 (8) | |
| Previous | 3 (2) | 67 (4) | 70 (4) | |
| Current | 182 (89) | 1521 (88) | 1703 (88) | |
| Comorbidities >10% in total population | ||||
| Anxiety/depression | 36 (18) | 316 (18) | 352 (18) | |
| Hepatitis C | 16 (8) | 268 (16) | 284 (15) | |
a
Disclosure to close/intimate relations (n = 1481), to extended relations (n = 166), or full disclosure (n = 77).
b
Chi-square (categorical variables) or Wilcoxon–Mann–Whitney (continuous variables) test, disclosed versus nondisclosed.
c
Median (interquartile range).
d
For women living with a partner (no disclosure, n = 27; any disclosure, n = 486; total, n = 513).